Controlled drug release applications of the inclusion complex of peracetylated-β-cyclodextrin and water-soluble drugs formed in supercritical carbon dioxide

Supercritical carbon dioxide (scCO2) processing was performed with mixtures of CO2-soluble peracetylated-β-cyclodextrin (PAc-β-CD) heptakis(2,3,6-tri-O-acetyl)-β-cyclodextrin, and highly water-soluble drug molsidomine (MOL) to prepare inclusion complexes of MOL and PAc-β-CD. The MOL/PAc-β-CD inclusion complex was confirmed by differential scanning calorimetry, X-ray diffractometry, and 1H NMR analyses. The complexes were further investigated for their potential use in controlled drug delivery applications. The in-vitro release of MOL from the peanut oil suspensions into aqueous phase was found to be significantly retarded by the complexation with PAc-β-CD, mainly due to the hydrophobic properties associated with the PAc-β-CD.